航天智造(300446.SZ):智能座艙產品與相關主機廠聯合研發,目前已經實現部分銷售
格隆匯8月6日丨航天智造(300446.SZ)在投資者互動平台表示,公司汽車零部件智能座艙產品圍繞智能光電、電驅電控、輕量環保、精緻裝飾四大技術領域進行創新升級,智能光電領域突破動態光源交互技術,建成智能數字格柵研發能力;電驅電控領域掌握微電機驅動與控制技術,實現電動風口、移動副板、電動桌板等產品集成研發能力;輕量環保領域掌握麻纖維研發與製造技術,完成複合材料門模塊技術儲備;精緻裝飾領域突破真木類裝飾產品關鍵技術,建立真木裝飾產品自研自制能力。 公司智能座艙產品與相關主機廠聯合研發,打造豐富的人機交互路徑,能夠有效提升用户的安全感與舒適感,目前已經實現部分銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.